You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 248 No. 21, December 3, 1982 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (117)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Sulindac

A Potentially Renal-Sparing Nonsteroidal Anti-inflammatory Drug

Robert D. Bunning, MD; Werner F. Barth, MD

JAMA. 1982;248(21):2864-2867.


Abstract

Three patients experienced rapidly reversible azotemia related to the use of naproxen or ibuprofen but tolerated full-dose sulindac. This article discusses renal toxicity of nonsteroidal anti-inflammatory drugs (NSAIDs), with emphasis on the role of inhibition of prostaglandin synthesis, and reviews evidence supporting a renal-sparing property of sulindac. The current literature assumes that all NSAIDs possess a similar potential for renal toxicity. The data presented suggest that sulindac has less potential for renal toxicity and may be the preferred NSAID for use in patients with impaired renal function.

(JAMA 1982;248:2864-2867)



Author Affiliations

From the Section of Rheumatology, Washington Hospital Center, Washington, DC.


Footnotes

Reprint requests to Section of Rheumatology, Room 2A-58, Washington Hospital Center, 110 Irving St NW, Washington, DC 20010 (Dr Barth).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Drug-induced heart failure
Feenstra et al.
J Am Coll Cardiol 1999;33:1152-1162.
ABSTRACT | FULL TEXT  

Chronic Renal Insufficiency: A Diagnostic and Therapeutic Approach
Rahman and Smith
Arch Intern Med 1998;158:1743-1752.
ABSTRACT | FULL TEXT  

NSAIDs: Are There Any Differences?
Kaplan and Swain
Arch Fam Med 1993;2:1167-1174.
ABSTRACT  

Cost-Conscious Prescribing of Nonsteroidal Anti-inflammatory Drugs for Adults With Arthritis: A Review and Suggestions
Greene and Winickoff
Arch Intern Med 1992;152:1995-2002.
ABSTRACT  

Renal Effects of Ibuprofen, Piroxicam, and Sulindac in Patients with Asymptomatic Renal Failure: A Prospective, Randomized, Crossover Comparison
Whelton et al.
ANN INTERN MED 1990;112:568-576.
ABSTRACT  

Salsalate Exacerbation of Chronic Renal Insufficiency: Relation to Inhibition of Prostaglandin Synthesis
Abraham and Stillman
Arch Intern Med 1987;147:1674-1676.
ABSTRACT  

Cirrhotic Ascites: Pathophysiology, Diagnosis, and Management
ROCCO and WARE
ANN INTERN MED 1986;105:573-585.
ABSTRACT  

Renal Papillary Necrosis in Children With Chronic Arthritis
Allen et al.
Arch Pediatr Adolesc Med 1986;140:20-22.
ABSTRACT  

Piroxicam-Induced Renal Disease
Mitnick and Klein
Arch Intern Med 1984;144:63-64.
ABSTRACT  

Zomepirac-Induced Renal Failure
Miller et al.
Arch Intern Med 1983;143:1171-1173.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.